What is ipilimumab? Unveiling the Immunotherapy for Cancer Treatment
•
4 min read
First approved by the FDA in March 2011, ipilimumab (brand name Yervoy) is a powerful immune checkpoint inhibitor that has revolutionized the treatment of advanced melanoma and other cancers. By harnessing the body's own immune system, this immunotherapy can help control and fight the spread of cancerous cells.
